Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

Boris Tchernychev, PhD, Raghunath Ramanarasimhaiah, MD, Guang Liu, PhD, Katherine Hall, PhD, Regina Margaret Graul, PhD, Jaime Masferrer, PhD

Blood (2019) 134 (Supplement_1): 3554.

https://doi.org/10.1182/blood-2019-127361

Published: 2019

Journal Articles

Constitutively Activated STAT3 Induces the Production of PTX3 That Contributes to the Induction of Bone Marrow Reticulin Fibrosis in Patient with CLL

Uri Rozovski, MD, David M. Harris, PhD, Ping Li, PhD, Zhiming Liu, BS, Taghi Manshouri, PhD, Ivo Veletic, MD, Preetesh Jain, MBBS,MDDM,PhD, Alessandra Ferrajoli, MD, Jan A. Burger, MD PhD, Prithviraj Bose, MD, Philip A. Thompson, MBBS, Nitin Jain, MD, Srdan Verstovsek, MD PhD, William G. Wierda, MD PhD, Michael J Keating, MBBS, Zeev E. Estrov, MD

Blood (2019) 134 (Supplement_1): 3024.

https://doi.org/10.1182/blood-2019-124183

Published: 2019

Journal Articles

SLAMF7 high CD16 negative Monocytes Increase in Peripheral Blood of Patients with Myelofibrosis in Correlation with JAK2V617F Mutation

Takaaki Maekawa, MD, Shoichiro Kato, MD, Yosuke Okada, MD, Noriaki Tachi, MD, Masahiro Teramoto, MD, Toshikuni Kawamura, MD, Yukiko Osawa, PhD, Shinichi Kobayashi, MD PhD, Ken Sato, MD PhD, Michihiro Hashimoto, PhD, Shinya Suzu, PhD, Kensuke Usuki, MD PhD, Soji Morishita, PhD, Marito Araki, PhD, Norio Komatsu, MD PhD, Fumihiko Kimura, Prof, MD PhD

Blood (2018) 132 (Supplement 1): 4330.

https://doi.org/10.1182/blood-2018-99-110916

Published: 2018

Journal Articles

Increased Pentraxin-3 Correlates with the Activity of the Neoplastic Clone in Primary Myelofibrosis

Ivo Veletic, MD, Taghi Manshouri, Kate J Newberry, PhD, Joseph E Bove, IV, Ying Zhang, MDMS, Zeev Estrov, MD, Srdan Verstovsek, MD PhD

Blood (2017) 130 (Supplement 1): 5284.

https://doi.org/10.1182/blood.V130.Suppl_1.5284.5284

Published: 2017

Journal Articles

Dose-Dependent Progressive Immunotherapeutic Clearance of Systemic Amyloid Deposits By Repeated Doses of Antibody to Serum Amyloid P Component (SAP)

Mark B Pepys, MDPhDFRS FMedSci, Louise M Cookson, BSc, Sharon V Barton, BSc MSc, Alienor C Berges, PharmD, Thirusha Lane, RN MSc, David Hutt, BAppSc, Marianna Fontana, MD, James C Moon, MD, Julian D Gillmore, MDPhDFRCP, Ashutosh Wechalekar, MDFRCPath FRCP, Philip N Hawkins, MDPhDFMedSci, Duncan B Richards, DM FRCP

Blood (2015) 126 (23): 1836.

https://doi.org/10.1182/blood.V126.23.1836.1836

Published: 2015

Journal Articles

Evidence for Transient Acute Liver Injury in Mouse Models of Sickle Cell Disease during Steady State Health

Nancy J. Wandersee, PhD, Sandra L. Holzhauer, Dawn M. Retherford, Thomas D. Foster, Cheryl A. Hillery, MD

Blood (2014) 124 (21): 1373.

https://doi.org/10.1182/blood.V124.21.1373.1373

Published: 2014

Journal Articles

Drug-Induced Amyloidosis: A Proteomic Insight Into 52 Cases

Anita D'Souza, MD, Jason D Theis, BS, Julie A Vrana, Ph.D., Ahmet Dogan, MD, PhD

Blood (2013) 122 (21): 1871.

https://doi.org/10.1182/blood.V122.21.1871.1871

Published: 2013

Journal Articles

Risk Of Progression Of Localised Amyloidosis To Systemic Disease In 606 Patients Over 30 Years

Shameem Mahmood, MRCP. FRCPath, Sajitha Sachchithanantham, MRCP. FRCPath, Frank Bridoux, Thirusha Lane, RN, Lisa Rannigan, RN, Darren Foard, RN, Rabya Sayed, MRCP, Ketna Patel, MRCP, Marianna Fontanna, MD, Carol Whelan, MD, Helen J Lachmann, MD, FRCP, Julian D Gillmore, MD, Philip N Hawkins, MD, Ashutosh Wechalekar, MD FRCPath

Blood (2013) 122 (21): 3143.

https://doi.org/10.1182/blood.V122.21.3143.3143

Published: 2013

Journal Articles

Factor XI Deficiency Reduces The Inflammatory Response To Polymicrobial Sepsis In Mice

Charles E. Bane, jr., DVM, Kelli L. Boyd, DVM, Ph.D., Erik I. Tucker, Ph.D., Stephen T. Smiley, Ph.D., Andras Gruber, MD, David Gailani, MD

Blood (2013) 122 (21): 201.

https://doi.org/10.1182/blood.V122.21.201.201

Published: 2013

Journal Articles

In AL Amyloidosis, Both Oral Melphalan and Dexamethasone (Mel-Dex) and Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Have Similar Efficacy as Upfront Treatment.

Simon DJ Gibbs, Julian D Gillmore, Prayman T Sattianayagam, Mark Offer, Helen J Lachmann, Philip N Hawkins, Ashutosh D Wechalekar

Blood (2009) 114 (22): 745.

https://doi.org/10.1182/blood.V114.22.745.745

Published: 2009

Journal Articles

Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) for the Treatment of Systemic AL Amyloidosis: Long Term Outcomes among 202 Patients.

Si mon DJ Gibbs, Prayman T Sattianayagam, Helen J Lachmann, Mark Offer, Julian D Gillmore, Philip N Hawkins, Ashutosh Wechalekar

Blood (2008) 112 (11): 1733.

https://doi.org/10.1182/blood.V112.11.1733.1733

Published: 2008

Journal Articles

A Clinical Test for the Identification of Amyloid Proteins in Biopsy Specimens by a Novel Method Based on Laser Microdissection and Mass Spectrometry.

Julie A. Vrana, PhD, Jeffrey D. Gamez, Jason D. Theis, Timothy B. Plummer, Robert H. Bergen, Ph.D., Steven R. Zeldenrust, M.D., Paul J. Kurtin, M.D., Karen L. Grogg, M.D., Ahmet Dogan, M.D./Ph.D.

Blood (2007) 110 (11): 1480.

https://doi.org/10.1182/blood.V110.11.1480.1480

Published: 2007

Journal Articles

A Profile of 44 Long Term Survivors (>10yrs) with AL Amyloidosis.

Ashutosh D. Wechalekar, MD, Helen J. Lachmann, MD, Julian D. Gillmore, MD, PhD, Philip N. Hawkins, PhD, FRCP

Blood (2007) 110 (11): 4765.

https://doi.org/10.1182/blood.V110.11.4765.4765

Published: 2007

Journal Articles

Transgenic sickle mice have vascular inflammation

John D. Belcher, Christopher J. Bryant, Julia Nguyen, Paul R. Bowlin, Miroslaw C. Kielbik, John C. Bischof, Robert P. Hebbel, Gregory M. Vercellotti

Blood (2003) 101 (10): 3953–3959.

https://doi.org/10.1182/blood-2002-10-3313

Published: 2003

NARROW

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

Constitutively Activated STAT3 Induces the Production of PTX3 That Contributes to the Induction of Bone Marrow Reticulin Fibrosis in Patient with CLL

SLAMF7 high CD16 negative Monocytes Increase in Peripheral Blood of Patients with Myelofibrosis in Correlation with JAK2V617F Mutation

Increased Pentraxin-3 Correlates with the Activity of the Neoplastic Clone in Primary Myelofibrosis

Dose-Dependent Progressive Immunotherapeutic Clearance of Systemic Amyloid Deposits By Repeated Doses of Antibody to Serum Amyloid P Component (SAP)

Evidence for Transient Acute Liver Injury in Mouse Models of Sickle Cell Disease during Steady State Health

Drug-Induced Amyloidosis: A Proteomic Insight Into 52 Cases

Risk Of Progression Of Localised Amyloidosis To Systemic Disease In 606 Patients Over 30 Years

Factor XI Deficiency Reduces The Inflammatory Response To Polymicrobial Sepsis In Mice

In AL Amyloidosis, Both Oral Melphalan and Dexamethasone (Mel-Dex) and Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Have Similar Efficacy as Upfront Treatment.

Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) for the Treatment of Systemic AL Amyloidosis: Long Term Outcomes among 202 Patients.

A Clinical Test for the Identification of Amyloid Proteins in Biopsy Specimens by a Novel Method Based on Laser Microdissection and Mass Spectrometry.

A Profile of 44 Long Term Survivors (>10yrs) with AL Amyloidosis.

Transgenic sickle mice have vascular inflammation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only